-
1
-
-
0027139351
-
Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B
-
Adler-Moore, J. P., and R. T. Proffitt. 1993. Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J. Liposome Res. 3:429-450.
-
(1993)
J. Liposome Res.
, vol.3
, pp. 429-450
-
-
Adler-Moore, J.P.1
Proffitt, R.T.2
-
2
-
-
3042655225
-
-
Fujisawa USA, Inc., Deerfield, Ill.
-
Anonymous. 1995. Data on file. Fujisawa USA, Inc., Deerfield, Ill.
-
(1995)
Data on File
-
-
-
3
-
-
0014032869
-
Pharmacology, toxicity, and therapeutic usefulness of amphotericin B
-
Buler, W. T. 1966. Pharmacology, toxicity, and therapeutic usefulness of amphotericin B. JAMA 195:127-131.
-
(1966)
JAMA
, vol.195
, pp. 127-131
-
-
Buler, W.T.1
-
4
-
-
0028335155
-
Non-clinical studies of the efficacy, pharmacokinetics and safety of amphotericin B colloidal dispersion (ABCD)
-
Dayan, A. D., and P. K. Working. 1994. Non-clinical studies of the efficacy, pharmacokinetics and safety of amphotericin B colloidal dispersion (ABCD). Round Table Ser. R. Soc. Med. Press 32:12-26.
-
(1994)
Round Table Ser. R. Soc. Med. Press
, vol.32
, pp. 12-26
-
-
Dayan, A.D.1
Working, P.K.2
-
5
-
-
0025741787
-
Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective
-
Fielding, R. M. 1991. Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective. Clin. Pharmacokinet. 21:155-164.
-
(1991)
Clin. Pharmacokinet.
, vol.21
, pp. 155-164
-
-
Fielding, R.M.1
-
6
-
-
0026595038
-
Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs
-
Fielding, R. M., A. W. Singer, L. H. Wang, S. Babbar, and L. S. S. Guo. 1992. Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs. Antimicrob. Agents Chemother. 36:299-307.
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 299-307
-
-
Fielding, R.M.1
Singer, A.W.2
Wang, L.H.3
Babbar, S.4
Guo, L.S.S.5
-
7
-
-
0028140216
-
Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: The potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection
-
Francis, P., L. W. Lee, A. Hoffman, J. Peter, A. Francesconi, J. Bacher, J. Shelhamer, P. Pizzo, and T. J. Walsh. 1994. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J. Infect. Dis. 169:356-368.
-
(1994)
J. Infect. Dis.
, vol.169
, pp. 356-368
-
-
Francis, P.1
Lee, L.W.2
Hoffman, A.3
Peter, J.4
Francesconi, A.5
Bacher, J.6
Shelhamer, J.7
Pizzo, P.8
Walsh, T.J.9
-
8
-
-
0027314254
-
Amphotericin B and its delivery by liposomal and lipid formulations
-
Gates, C., and R. J. Pinney. 1993. Amphotericin B and its delivery by liposomal and lipid formulations. J. Clin. Pharm. Ther. 18:147-153.
-
(1993)
J. Clin. Pharm. Ther.
, vol.18
, pp. 147-153
-
-
Gates, C.1
Pinney, R.J.2
-
9
-
-
0026009404
-
Overview of liposomes
-
Gorgialis, G. 1991. Overview of liposomes. J. Antimicrob. Ther. 28:39-48.
-
(1991)
J. Antimicrob. Ther.
, vol.28
, pp. 39-48
-
-
Gorgialis, G.1
-
10
-
-
0026731426
-
Liposomal and lipid formulations of amphotericin B
-
Janknegt, J., S. de Marie, I. A. J. M. Bakker-Woudenberg, and D. J. A. Crommelin. 1992. Liposomal and lipid formulations of amphotericin B. Clin. Pharmacokinet. 23:279-291.
-
(1992)
Clin. Pharmacokinet.
, vol.23
, pp. 279-291
-
-
Janknegt, J.1
De Marie, S.2
Bakker-Woudenberg, I.A.J.M.3
Crommelin, D.J.A.4
-
11
-
-
0024474065
-
Incorporation of amphotericin B (AMB) into liposomes alters the AMB-induced acute nephrotoxicity in rabbits
-
Joly, V., F. Dromer, J. Barge, P. Yeni, N. Seta, G. Molas, and C. Carbon. 1989. Incorporation of amphotericin B (AMB) into liposomes alters the AMB-induced acute nephrotoxicity in rabbits. J. Pharm. Exp. Ther. 251:311-316.
-
(1989)
J. Pharm. Exp. Ther.
, vol.251
, pp. 311-316
-
-
Joly, V.1
Dromer, F.2
Barge, J.3
Yeni, P.4
Seta, N.5
Molas, G.6
Carbon, C.7
-
12
-
-
0028266748
-
Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits
-
Lee, J. W., M. A. Amanthea, P. A. Francis, E. E. Navarro, J. Bacher, P. A. Pizzo, and T. J. Walsh. 1994. Pharmacokinetics and safety of a unilamellar liposomal formulation of amphotericin B (AmBisome) in rabbits. Antimicrob. Agents Chemother. 38:713-718.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 713-718
-
-
Lee, J.W.1
Amanthea, M.A.2
Francis, P.A.3
Navarro, E.E.4
Bacher, J.5
Pizzo, P.A.6
Walsh, T.J.7
-
13
-
-
0025821201
-
Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats
-
Longuet, P., V. Joly, P. Amirault, N. Seta, C. Carbon, and P. Yeni. 1991. Limited protection by small unilamellar liposomes against the renal tubular toxicity induced by repeated amphotericin B infusions in rats. Antimicrob. Agents Chemother. 35:1303-1308.
-
(1991)
Antimicrob. Agents Chemother.
, vol.35
, pp. 1303-1308
-
-
Longuet, P.1
Joly, V.2
Amirault, P.3
Seta, N.4
Carbon, C.5
Yeni, P.6
-
14
-
-
0020584090
-
Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B
-
Lopez-Bernstein, G., R. Meheta, R. L. Hopfer, K. Mills, L. Kasi, K. Meheta, V. Fainstein, M. Luna, E. M. Hersh, and R. Juliano. 1983. Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J. Infect. Dis. 147:939-945.
-
(1983)
J. Infect. Dis.
, vol.147
, pp. 939-945
-
-
Lopez-Bernstein, G.1
Meheta, R.2
Hopfer, R.L.3
Mills, K.4
Kasi, L.5
Meheta, K.6
Fainstein, V.7
Luna, M.8
Hersh, E.M.9
Juliano, R.10
-
15
-
-
0344296617
-
-
MicroMath Scientific Software, Salt Lake City, Utah
-
MicroMath Scientific Software. 1993. RStrip. Exponential stripping and parameter estimation. MicroMath Scientific Software, Salt Lake City, Utah.
-
(1993)
RStrip. Exponential Stripping and Parameter Estimation
-
-
-
16
-
-
0026043820
-
Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents
-
Proffitt, R. T., A. Sartorius, S. M. Chiang, L. Sullivan, and J. P. Adler-Moore. 1991. Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J. Antimicrob. Chemother. 28(Suppl. B):49-61.
-
(1991)
J. Antimicrob. Chemother.
, vol.28
, Issue.SUPPL. B
, pp. 49-61
-
-
Proffitt, R.T.1
Sartorius, A.2
Chiang, S.M.3
Sullivan, L.4
Moore, J.P.5
-
17
-
-
0028960767
-
Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leukopenic mice infected with Candida albicans
-
van Eaten, E. W. M., M. Otte-Lambillion, W. van Vianen, M. T. ten Kate, and I. A. J. M. Bakker-Woudenberg. 1995. Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leukopenic mice infected with Candida albicans. J. Antimicrob. Chemother. 35:509-519.
-
(1995)
J. Antimicrob. Chemother.
, vol.35
, pp. 509-519
-
-
Van Eaten, E.W.M.1
Otte-Lambillion, M.2
Van Vianen, W.3
Ten Kate, M.T.4
Bakker-Woudenberg, I.A.J.M.5
-
18
-
-
0029017725
-
Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy
-
Walsh, T. J., K. Garrett, E. Feuerstein, M. Girton, M. Allende, J. Bacher, A. Francesconi, R. Schaufele, and P. A. Pizzo. 1995. Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy. Antimicrob. Agents Chemother. 39:1065-1069.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 1065-1069
-
-
Walsh, T.J.1
Garrett, K.2
Feuerstein, E.3
Girton, M.4
Allende, M.5
Bacher, J.6
Francesconi, A.7
Schaufele, R.8
Pizzo, P.A.9
|